Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 CAD | -2.04% | -8.28% | -19.55% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.55% | 80.2M | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- RBC Capital on Takeaways From Oncolytics' KOL Call on Pancreatic Cancer, Updated Interim Ph 1/2 GOBLET Study Data